Using enhanced DNA technology, the lab has designed DNA vaccines that drive immune responses in prophylactic or therapeutic settings against Human Immunodeficiency Virus (HIV), Dengue (DV), Chikungunya virus (CHIKV), Middle
Eastern Respiratory Syndrome (MERS) virus, and Zika Virus (ZV).
A declaration by the panel of a global crisis would give the WHO power to issue temporary recommendations on travel restrictions or other ways to control the spread of Middle
Eastern Respiratory Syndrome (MERS) virus, which has infected 79 people and killed 42 of them.